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Abstract. Circulating tumor cell (CTC) clusters, arising from multicellular groupings in a primary tumor, greatly
elevate the metastatic potential of cancer compared with single CTCs. High-throughput detection and quanti-
fication of CTC clusters are important for understanding the tumor metastatic process and improving cancer
therapy. Here, we applied a linear-array-based photoacoustic tomography (LA-PAT) system and improved
the image reconstruction for label-free high-throughput CTC cluster detection and quantification in vivo. The
feasibility was first demonstrated by imaging CTC cluster ex vivo. The relationship between the contrast-to-
noise ratios (CNRs) and the number of cells in melanoma tumor cell clusters was investigated and verified.
Melanoma CTC clusters with a minimum of four cells could be detected, and the number of cells could be com-
puted from the CNR. Finally, we demonstrated imaging of injected melanoma CTC clusters in rats in vivo.
Similarly, the number of cells in the melanoma CTC clusters could be quantified. The data showed that larger
CTC clusters had faster clearance rates in the bloodstream, which agreed with the literature. The results
demonstrated the capability of LA-PAT to detect and quantify melanoma CTC clusters in vivo and showed
its potential for tumor metastasis study and cancer therapy. © 2016 Society of Photo-Optical Instrumentation Engineers
(SPIE) [DOI: 10.1117/1.JBO.22.4.041004]
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1 Introduction
Metastasis, the spread of cancer cells from a primary site to dis-
tant organs leading to the growth of new tumors there, accounts
for the majority of cancer deaths.1 Blood-borne metastasis
comprises multiple steps, including intravazation, survival in
the blood circulation, extravazation, and secondary growth in
the distant organs, in which the rare circulating tumor cells
(CTCs) are the key determinants of metastatic propensity.2
While most CTCs survive in the blood circulation in the
form of single cells, CTC clusters also exist and elevate the
metastatic potential by 23 to 50 folds.3 Detection and quantifi-
cation of CTC clusters will provide valuable insights into meta-
stasis as well as cancer therapy. Because the presence of CTCs is
positively correlated with metastatic propensity,4 the detection
and enumeration of rare CTCs will help to better evaluate the
melanoma stage and predict metastatic potential during the
diagnosis. In addition, tracking the concentration of CTCs in
the circulatory system during treatment will likely be valuable
indicators of both tumor responses to therapy and melanoma
progression.
Taking advantage of tumor-specific physical and biological
properties, such as sizes and surface biomarkers, multiple tech-
nologies have been developed to capture and isolate single
CTCs and CTC clusters.5–7 However, most of these existing
technologies require blood to be drawn to isolate and capture
CTCs ex vivo, reducing the effective CTC detection sensitivity.
Optical imaging technologies, such as confocal microscopy,
in vivo flow cytometry, and optical coherence tomography,
have been applied to detect CTCs in vivo.8–11 However, suffering
from strong optical scattering in biological tissue, these tech-
niques have shallow penetration, limiting them to imaging
only small blood vessels, which results in low throughput for
CTC detection.
By integrating optical excitation with acoustic detection,
photoacoustic tomography (PAT) combines rich optical absorp-
tion contrasts with high ultrasonic spatial resolution at depths.12
With 100% relative sensitivity to optical absorption, i.e., a given
percentage change in the optical absorption yields the same
percentage change in the photoacoustic signal, PAT achieves
structural, functional, metabolic, and mechanical imaging of
biological tissue.13–17 Taking advantage of the strong optical
absorption of melanin, photoacoustic techniques have been suc-
cessfully used for imaging and sensing melanoma CTCs.
Photoacoustic flowmetry successfully detected circulating mela-
noma cells in human blood.18,19 Photoacoustic flow cytometry
enables long-term monitoring of melanoma CTCs in vivo.
However, these sensing techniques provide inadequate spatial
resolution to further characterize melanoma CTCs.20 The micro-
scopic implementation of PAT, optical-resolution photoacoustic
microscopy (OR-PAM), images single melanoma CTCs in the
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blood flows with high spatial-temporal resolution.21 While
providing valuable insights into CTCs on a single-cell level,
OR-PAM suffers from low throughput.
Here, we apply a linear-array-based photoacoustic tomogra-
phy (LA-PAT) system for label-free high-throughput melanoma
CTC cluster detection and quantification in vivo. Exploiting the
strong optical absorption of melanin in the melanoma tumor
cells, LA-PAT can achieve label-free detection of melanoma
CTC clusters in vivo. By analyzing the contrast-to-noise ratios
(CNRs) of the photoacoustic signals, LA-PAT can quantify the
number of cells in the CTC clusters and study their circulating
kinetics in the bloodstream.
2 Materials and Methods
2.1 Linear-Array-Based Photoacoustic Tomography
System
To image melanoma CTC clusters, we applied an LA-PAT sys-
tem based on a handheld probe and improved the image
reconstruction.22 A tunable optical parametric oscillator laser
(680 to 970 nm, 20-Hz pulse repetition rate) was used for illu-
mination. An excitation wavelength of 680 nm was chosen to
achieve the optimal contrast between melanoma tumor cells
and blood [Fig. 1(a)]. The laser beam was coupled into a
fiber optical bundle that bifurcated into two optical fiber bun-
dles. Laser beams coming out of the two optical fiber bundle
strips (20 × 1.25 mm2) excited the object at an angle of
incidence of 30 deg relative to the imaging plane [Figs. 1(b)
and 1(c)]. During the experiments, the fluence on the tissue sur-
face was about 10 mJ∕cm2, well within the 20 mJ∕cm2 safety
limit set by the American National Standards Institute. The
generated photoacoustic waves were detected by a linear array
ultrasonic transducer (Visualsonics, Inc., LZ250, 21-MHz
center frequency, 78% one-way bandwidth, 256 elements,
23 × 3 mm2 array size). The spatial resolutions of the system
were 119 μm in the lateral direction, 86 μm in the axial direc-
tion, and 1237 μm in the elevational direction.23 Because there
were only 64 channels in the data acquisition unit, four-to-one
multiplexing was applied during image acquisition. For each
laser pulse, the generated photoacoustic signals were captured
sequentially by a quarter segment of the linear array (i.e.,
elements 1 to 64, 65 to 128, 129 to 192, and 193 to 256).
Once the data were acquired from all four quarter segments,
a two-dimensional photoacoustic image was reconstructed
with the universal back-projection algorithm developed by
our group.24 The reconstructed photoacoustic images were
displayed in an imaging station (Vevo LAZR, Visualsonics,
Inc.). Determined by the 20-Hz laser repetition rate and the
four-to-one multiplexing in image acquisition, the frame rate
was 5 frames∕s.
2.2 Tumor Cell Culture and Cluster Preparation
B16F10 melanoma tumor cells obtained from ATCC® were
cultured in Dulbecco’s modified Eagle’s medium (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen) at
37°C in air with 5% CO2. Upon reaching 80% confluence,
cells growing in a monolayer were incubated with 0.25% tryp-
sin-EDTA solution (Invitrogen) to generate floating cell clusters
of various sizes. After adding serum-containing medium to
neutralize trypsin, the floating cell clusters were handled in
two ways. To mimic melanoma CTC clusters of various sizes,
floating cell clusters totaling 1 × 106 cells were directly sus-
pended in 1 mL of bovine blood for ex vivo experiments or
in 1 mL of collected rat blood for tail vein injection. To generate
melanoma cell clusters of a certain size for CNR analysis,
instead of directly suspending the floating cell clusters in
blood, the clusters were mechanically dissociated by pipetting
to generate a single-cell suspension. The single cells were then
suspended in a blood–agar mixture at a desired concentration
and then cooled to become solid. The concentration was con-
trolled so that within each resolution voxel of LA-PAT there
was a certain number of melanoma cells, i.e., 5, 10, 20, 30,
40, or 50. The solid mixture was then mechanically dissociated
into particles smaller than the resolution voxel of LA-PAT to
generate cell clusters of a certain size. The particles were
then suspended in 1 mL of bovine blood for CNR analysis.
2.3 Phantom Preparation
Silicone microtubes with 0.76 mm inner diameter (11-189-15C,
Fisher Scientific) were perfused with bovine blood (905, Quad-
Five) to mimic blood vessels. The microtubes were embedded
3 mm deep in tissue-mimicking gelatin phantoms. Optical scat-
tering similar to that in biological tissue was achieved by adding
1% intralipid to the gelatin phantoms. Melanoma tumor cell
clusters suspended in bovine blood were pumped through
the microtubes with a syringe. A syringe pump (BSP-99M,
Braintree Scientific) controlled the blood flow speed.
Fig. 1 Absorption spectra of melanin and hemoglobin, and the front
and side views of the handheld probe for LA-PAT. (a) Absorption
spectra of melanin and hemoglobin. An excitation wavelength of
680 nm was chosen for the optimal CNR. (b) Lateral view of the
handheld probe. (c) Elevational view of the handheld probe with
a zoomed-in view.
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2.4 Experimental Animals and CTC Cluster
Injection
All experimental animal procedures were carried out in con-
formity with the laboratory animal protocol approved by the
Animal Studies Committee at Washington University in St.
Louis. Male nude rats (Hsd∶RH-Foxn1rnu∕Foxn1þ, Harlan
Co.; 12- to 13-weeks old; ∼330 to 350 g body weight) were
used for all in vivo experiments. Throughout the experiments,
the rats were kept under anesthesia with 2% vaporized isoflur-
ane. A homemade animal holder immobilized the rats during
the experiments.
3 Results
3.1 CNR Analysis of Melanoma Tumor Cell
Clusters
To detect and quantify CTC clusters, we first used LA-PAT to
image melanoma tumor cell clusters of known sizes and ana-
lyzed their CNRs. Clusters with an average of 5, 10, 20, 30,
40, and 50 cells were suspended in blood and imaged by
LA-PAT. The CNR for each cluster was calculated [Fig. 2(a)].
The average CNRs were plotted as a function of the number of
cells in the clusters, as measured with an optical microscope
(OM) (Eclipse TS100, Nikon) [Fig. 2(b)]. The experimental
data were fitted to a linear function
EQ-TARGET;temp:intralink-;e001;63;150CNR ¼ 0.46 × N: (1)
Here, N represents the number of cells in a melanoma tumor cell
cluster. Based on a 6-dB CNR threshold, a minimum of four
cells can be resolved although this minimum was not directly
observed. To verify the relationship between the CNR and
the number of cells in the clusters, another independent
experiment was performed. Melanoma tumor cell clusters
consisting of a uniform but unknown number of cells were
equally divided into six groups. Three randomly chosen
groups were suspended in blood and imaged by LA-PAT.
The numbers of cells in the clusters were calculated based on
the CNRs and the relationship above. The other three groups
were examined with an OM to determine the numbers of cells
in the clusters. The number of cells in the melanoma tumor cell
clusters measured by LA-PAT and optical microscopy agreed
well with each other [Fig. 2(c)], confirming the relationship
between the numbers of cells in the clusters and the CNRs in
LA-PAT.
3.2 LA-PAT of CTC Clusters Ex Vivo
We then demonstrated the ability of LA-PAT to detect and
quantify CTC clusters ex vivo. A mixture of melanoma
tumor cell clusters of various sizes was equally divided into
six groups. Three randomly chosen groups were suspended in
blood, pumped through microtubes to mimic flowing melanoma
CTC clusters, and imaged by LA-PAT [Videos 1–3]. Each
melanoma tumor cell cluster was captured by LA-PAT multiple
times, and the average CNR was used to calculate the number of
cells in the cluster. Based on the calculated number of cells in
the clusters, the melanoma tumor cell clusters were divided into
three categories: ≤10, 11 to 20, and ≥21. Typical photoacoustic
images of the three categories are shown in Figs. 3(a)–3(c). The
other three groups were measured with an OM to determine the
numbers of cells in the clusters and were divided into the same
three categories. The size distributions of the clusters measured
by LA-PAT and optical microscopy agreed well with each other
with a correlation coefficient of 0.96 [Fig. 3(d)], and the results
further demonstrated the ability of LA-PAT to detect and quan-
tify melanoma CTC clusters.
Fig. 2 CNR analysis of melanoma tumor cell clusters. (a) CNR distributions measured with LA-PAT for
melanoma tumor cell clusters of different sizes. (b) Average CNRs in LA-PAT as a function of the
numbers of cells in melanoma tumor cell clusters. (c) The numbers of cells in melanoma tumor cell
clusters measured by LA-PAT agreed well with those measured by an OM.
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Fig. 3 LA-PAT of CTC clusters ex vivo. LA-PAT of a flowing melanoma tumor cell cluster with (a) 7 cells
(Video 1), (b) 14 cells (Video 2), and (c) 29 cells (Video 3). The cell numbers are calculated based on
the CNR curve in Fig. 2. (d) Distributions of the numbers of cells in melanoma tumor cell clusters,
as measured by LA-PAT and OM (Video 1, MP4, 1.91 MB [URL: http://dx.doi.org/10.1117/1.JBO.22
.4.041004.1]; Video 2, MP4, 2.01 MB [URL: http://dx.doi.org/10.1117/1.JBO.22.4.041004.2]; Video 3,
MP4, 1.84 MB [URL: http://dx.doi.org/10.1117/1.JBO.22.4.041004.3]).
Fig. 4 LA-PAT of CTC clusters in rat tail veins in vivo. (a) LA-PAT of CTC clusters in a rat tail vein
in vivo immediately after injection (Video 4). (b) LA-PAT of CTC clusters in the rat tail vein in vivo
45 min after injection (Video 5). (c) Clearance curves of small (≤10 cells), medium (11 to 20 cells),
and large (≥21 cells) CTC clusters in rat bloodstreams (Video 4, MP4, 604 kB [URL: http://dx.doi.org/
10.1117/1.JBO.22.4.041004.4]; Video 5, MP4, 613 kB [URL: http://dx.doi.org/10.1117/1.JBO.22.4
.041004.5]).
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3.3 LA-PAT of CTC Clusters In Vivo
To demonstrate the feasibility of LA-PAT in vivo, we imaged
melanoma CTC clusters injected into rats. Melanoma tumor
cell clusters suspended in 1 mL of rat blood at a concentration
of 1 × 106 cells∕mL were injected into the same rat from which
the blood was collected a few minutes earlier. The rat tail vein
was then monitored by LA-PAT for 45 min to study the circu-
lation kinetics and the clearance rates of CTC clusters. CTC
clusters were detected by LA-PAT immediately after injection
and during circulating in the rat bloodstreams [Figs. 4(a) and
4(b) and Videos 4 and 5]. The numbers of cells in the CTC clus-
ters were calculated based on the CNRs. The CTC clusters were
categorized into three groups based on the calculated number of
cells and the clearance curves of the three groups are shown in
Fig. 4(c). Larger CTC clusters showed faster clearance rates
from the bloodstream than smaller CTC clusters.
4 Discussion and Conclusions
Compared with single CTCs, CTC clusters are rarer, but have a
higher metastatic potential. CTC clusters have a faster clearance
rate, i.e., a shorter lifetime, in the bloodstream than single CTCs,
making them even more difficult to detect. Here, we applied
LA-PAT to detect and quantify melanoma CTC clusters in rat
in vivo. Since the spatial resolutions of LA-PATwere not enough
to resolve single melanoma tumor cells, the numbers of cells in
the CTC clusters were quantified based on the CNRs. A linear
relationship between the CNRs and the numbers of cells in the
CTC clusters was found and verified. In ex vivo experiments,
LA-PAT quantified the numbers of cells in the CTC clusters,
and the results were validated by an OM. In experiments in
vivo, LA-PAT detected and quantified melanoma CTC clusters
immediately after injection, as well as when they were circulat-
ing in the rat bloodstreams. The results by LA-PAT also showed
that larger CTC clusters have faster clearance rates.
The melanoma CTC detection sensitivity of LA-PAT is
determined by the CNR. Because the noise is dominated by
the fluctuating counts of red blood cells in each resolution
voxel, the detection sensitivity is largely dependent on the spa-
tial resolutions of LA-PAT. On one hand, to achieve single cell
sensitivity in CTC detection, a higher frequency ultrasonic
transducer could be used at the expense of penetration depth.
On the other hand, to achieve deeper imaging, a lower frequency
ultrasonic transducer can be employed, at the expense of CTC
detection sensitivity. The CTC detection sensitivity can be
further improved by performing spectral unmixing using multi-
wavelength illumination. To achieve multiwavelength imaging
of flowing CTCs, a second laser with a different wavelength
needs to be incorporated into the system.
It is worth pointing out that currently LA-PAT detects only
CTCs originating from primary tumors in which cells express
melanin. To detect CTCs originating from amelanotic melanoma
tumors, other tumor-specific physiological properties, such as
sizes and surface biomarkers, can be utilized. The quantification
of CTC cluster sizes is indeed based on the assumption that the
melanin content is relatively uniform in the tumor cells. This
assumption often holds true for tumor cells originating from
the same primary tumor. However, if there are several primary
tumors, it may affect the accuracy of quantifying CTC cluster
sizes.
LA-PAT has the potential to be a powerful tool for both pre-
clinical tumor metastasis study and clinical cancer diagnosis and
therapy. As a useful technique for researchers and scientists to
better understand the relationship between CTCs and tumor
metastasis, LA-PAT can employ ultrasonic transducers of
different frequencies for target vessels at various depths and
different animal models. Other physiological parameters,
including vessel diameter and blood flow speed, can be mea-
sured concurrently for further understanding of CTC flow
dynamics. LA-PAT can also be used by clinicians to monitor
the changes of CTC concentrations in patients’ circulatory sys-
tems and to evaluate the outcome of cancer therapy. To further
improve LA-PAT for such clinical applications, an automatic
CTC detection and counting algorithm should be developed.
Metastasis is a complex biological process that involves
multiple steps and many parameters. Photoacoustic imaging,
with the ability to quantify numerous parameters at multiple
scales based on the same optical absorption contrast, can
provide comprehensive information about tumor metastasis.
OR-PAM can study CTCs on a single-cell level.21 LA-PAT
has been demonstrated to detect and quantify CTC clusters.
In addition, photoacoustic imaging can measure other important
biological parameters, including the oxygen saturation of hemo-
globin, metabolic rate, and tumor stiffness,25–27 all of which are
closely related to metastasis.28–30 With the capability to detect
and quantify CTC clusters and the potential to provide multidi-
mensional information on tumor metastasis, LA-PAT is a prom-
ising tool for both preclinical cancer metastasis study and
clinical tumor therapy.
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